{"nctId":"NCT02815709","briefTitle":"Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy","startDateStruct":{"date":"2016-05"},"conditions":["Acute Pain"],"count":418,"armGroups":[{"label":"Treatment 1 Oliceridine","type":"EXPERIMENTAL","interventionNames":["Drug: Oliceridine"]},{"label":"Treatment 2 Oliceridine","type":"EXPERIMENTAL","interventionNames":["Drug: Oliceridine"]},{"label":"Treatment 3 Oliceridine","type":"EXPERIMENTAL","interventionNames":["Drug: Oliceridine"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Morphine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Morphine"]}],"interventions":[{"name":"Oliceridine","otherNames":[]},{"name":"Placebo","otherNames":[]},{"name":"Morphine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Has undergone primary, unilateral, first metatarsal bunionectomy (osteotomy and internal fixation) with no additional collateral procedures.\n* Experiences a pain intensity rating of moderate to severe acute pain.\n* Able to provide written informed consent before any study procedure.\n\nExclusion Criteria:\n\n* ASA Physical Status Classification System classification of P3 or worse.\n* Has surgical or post-surgical complications.\n* Has clinically significant medical conditions or history of such conditions that may interfere with the interpretation of efficacy, safety, or tolerability data obtained in the trial, or may interfere with the absorption, distribution, metabolism, or excretion of drugs.\n* Has previously participated in another TRV130 clinical study.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Patients Who Respond to Study Medication at the 48-hr Numeric Pain Rating Scale (NRS) Assessment Compared to Placebo.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"49","spread":null},{"groupId":"OG002","value":"52","spread":null},{"groupId":"OG003","value":"12","spread":null},{"groupId":"OG004","value":"54","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Respiratory Safety Events Compared to Morphine.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"11","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"14","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Respiratory Safety Events Compared to Morphine.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.21","spread":"1.796"},{"groupId":"OG001","value":"3.44","spread":"1.186"},{"groupId":"OG002","value":"3.34","spread":"0.797"},{"groupId":"OG003","value":"2.94","spread":"1.074"},{"groupId":"OG004","value":"5.14","spread":"1.060"}]}]}]},{"type":"SECONDARY","title":"Odds Ratio of Patients Who Respond to Study Medication at the 48-hr NRS Assessment Compared to Morphine.","description":"Odds ratio of 48-hour responder analysis versus morphine. Number of patients who responded to study medication at the 48-hr NRS assessment is captured in the primary outcome measure.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":null},{"groupId":"OG001","value":"2.54","spread":null},{"groupId":"OG002","value":"2.89","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Treatment-related Adverse Events.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null},{"groupId":"OG001","value":"59","spread":null},{"groupId":"OG002","value":"65","spread":null},{"groupId":"OG003","value":"32","spread":null},{"groupId":"OG004","value":"68","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":76},"commonTop":["Nausea","Vomiting","Headache","Dizziness","Constipation"]}}}